Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI Francisco Coronel, García-Mena, Herrero, Calvo, Pérez-Flores, Cigarrán

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies Begoña Goyache-Goñi, Pedro Aranda-Lara, Armando Reyes-Engels, Miguel A. Frutos-Sanz, Domingo Hernández-Marrero

May blockade of the renin-angiotensin system be optimised in proteinuric nephropathy? Gema Fernández Juárez